Form D · Biotechnology
Frontier Health LLC
Las Vegas, NV · CIK 0002067960
Offering snapshot reported May 14, 2025 · SEC filing
- Reported sold
- $1.9M Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- May 1, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 14, 2025 | Initial | $1,900,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-546137
The offering includes securities to be acquired subject to performance milestones, so the amount and price are not currently known. The offering amount is evolving and is subject to change based on changes in the company?s ongoing capital requirements.
This is subject to change given difficult market conditions currently for securities offerings.
Source: Form D, filed May 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Andrew Fetyko | Executive, Promoter |
| David Robb | Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1350 East Flamingo Road #67
Las Vegas, NV, 89119
Las Vegas, NV, 89119